Industry insights
Lianbang Opens Yun Oxygen R&D Base in Chengdu
Reported by CCTV Business Channel
Chengdu Lianbang Medical Technology’s Yun Oxygen research and production base in the Shuangliu Economic Development Zone entered service at the end of August 2023, separating development and small-batch production of cloud-connected oxygen systems from the main plant. The project sits inside a district programme that then counted 18 national little giants and 105 provincial specialised SMEs.
Keywords: medical oxygen, PSA oxygen generator, Yun Oxygen, Chengdu Shuangliu
Chengdu Lianbang Medical Technology’s Yun Oxygen research and production base in the Shuangliu Economic Development Zone was due to enter service at the end of August 2023, according to a report by People’s Daily’s Sichuan channel that CCTV’s business channel republished on 20 July 2023.
The base is the company’s second manufacturing site in Shuangliu and is dedicated to cloud-connected oxygen supply — systems that generate oxygen on site and report their operating state remotely, rather than depending on delivered cylinders or liquid oxygen. For a hospital group or a hotel operator running oxygen across several buildings, that distinction changes who is responsible for uptime.
What the base adds
Lianbang has supplied medical oxygen generation, medical gas pipeline and plateau oxygen systems since 1997. The new site consolidates research and production for the Yun Oxygen line, which the company positions as a service rather than a box: the equipment generates oxygen from ambient air, and the cloud layer tracks purity, pressure, flow and maintenance intervals across installed sites.
The report framed the project as part of Shuangliu’s effort to build industrial chains around biomedicine and advanced manufacturing — the district’s phrase is “building circles and strengthening chains,” meaning it tries to keep suppliers, manufacturers and research institutes for one industry inside the same district.
For a distributor evaluating a supplier, the practical question is what a second site does to lead times and redundancy. A dedicated base separates R&D and small-batch production from the main plant, which usually shortens the path from a custom specification to a buildable unit. It also gives the company somewhere to run endurance testing without occupying a line that is producing for customers.
The pipeline behind the plant
Shuangliu’s support for the project is part of a structured programme for small and medium manufacturers. The district runs a three-tier ladder: innovative SMEs at the bottom, provincial “specialized and refined” SMEs in the middle, and national “little giants” at the top. Companies move up as they meet revenue, R&D intensity and market-share criteria.
At the time of the report the district had 18 national little giants, 105 provincial specialized SMEs and 134 innovative SMEs, and expected to pass 20 and 130 respectively by the end of 2023. The figures matter to an overseas buyer only indirectly, but they explain why a mid-sized Chinese equipment maker can invest in a new plant: the district shares the cost of R&D, certification and market entry.
- Provincial and municipal awards of RMB 500,000 and RMB 300,000 for a national little giant, with the district preparing a further RMB 300,000 recognition award.
- About RMB 78 million in combined provincial, municipal and district subsidies to little giants and provincial specialized SMEs over the previous three years.
- 150 published supply and demand lists and seven matchmaking events in 2022, intended to connect local manufacturers with buyers.
The district also runs a regular consultation session known as “enterprise coffee time.” It held 239 sessions in 2022, logged 776 company requests and reports a 100% resolution rate and 98.97% satisfaction. Those numbers are self-reported, but the mechanism — a standing channel where a factory can raise a permitting or supply problem — is the part that tends to matter when a project is on a construction schedule.
Why a second site matters for export buyers
Medical oxygen equipment is rarely bought off a catalogue. A hospital project needs a pressure and flow calculation, a pipeline layout, and documentation that matches the importing country’s rules. That work is engineering, not assembly, and it scales with engineering headcount rather than floor space.
A dedicated R&D base is therefore a signal about how a supplier intends to compete. Companies that stay in one crowded plant usually compete on price for standard units. Companies that build a second site for development are usually moving toward configured systems and service contracts — which is the segment where margins survive a freight quote.
The base was reported as “about to be commissioned” rather than completed. Buyers should ask for the commissioning date, the first product built there, and whether the quality management system certificate covers the new address — a detail that catches distributors out more often than the equipment itself.
The short version
A 29-year-old oxygen equipment maker added a second Shuangliu site dedicated to cloud-connected oxygen systems, backed by a district programme that subsidises R&D and certification for specialized manufacturers. For buyers, the near-term effects are shorter engineering lead times and a second production address to audit.
Source: CCTV Business Channel, republished from People’s Daily Sichuan, 20 July 2023 — https://jingji.cctv.com/2023/07/20/ARTIvl7VD4xTBUHMcuCOYsyp230720.shtml